4//SEC Filing
ANADYS PHARMACEUTICALS INC 4
Accession 0001209191-06-064377
CIK 0001128495operating
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 8:37 PM ET
Size
9.1 KB
Accession
0001209191-06-064377
Insider Transaction Report
Form 4
YAROSHEVSKY GLANVILLE MARY
Senior Director, Human Capital
Transactions
- Award
Stock Option (Right to Buy)
2006-12-08+32,500→ 32,500 totalExercise: $4.88From: 2007-12-08Exp: 2016-12-07→ Common Stock (32,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable one year from the date of the grant with the remaining shares subject to the option vesting in equal monthly installments evenly over the next three year period such that all shares subject to the option will be fully vested and exercisable as of December 8, 2010.
Issuer
ANADYS PHARMACEUTICALS INC
CIK 0001128495
Entity typeoperating
Related Parties
1- filerCIK 0001128495
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 8:37 PM ET
- Size
- 9.1 KB